Rodon Biologics is a leading biotech CRO/CDMO with over 20 years of experience in recombinant product production and process development. We specialize in engineering, producing, analyzing, characterizing, and delivering recombinant proteins and small molecules from engineered microorganisms. Our comprehensive services cater to discovery, early-stage, and preclinical research, as well as manufacturing.

Originally established as Biotecnol in 1999, Rodon Biologics was created in 2013 to focus on providing high-quality services. In 2018, we became independent from Biotecnol after being acquired by the Portuguese Pharma CMO, Iberfar. Throughout our history, we have collaborated with a wide range of clients, from small start-ups to larger pharma and biotech companies on an international level.

At Rodon Biologics, we offer a range of services, from DNA to drug product. We can engineer, produce, and characterize products ranging from a few milligrams to tens of grams for initial research. We also provide support for continued development through the establishment of stable cell lines, robust scalable processes, and collaboration with CMOs for GMP manufacture during clinical trials.

Our dedication to customer satisfaction and our extensive experience make us the perfect partner for the development of your biotech products. Trust Rodon Biologics to be your reliable and innovative solution